BioRestorative Therapies (BRTX) FCF Margin (QoQ) (2012 - 2025)
BioRestorative Therapies (BRTX) FCF Margin (QoQ) (2012 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.94 Bn | 132.09 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.59 Bn | 78.60 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.67 Bn | 60.49 Bn | 1.37 Bn |
| 4 | Moderna | 57.81 Bn | 52.67 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.25 Bn | 37.15 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.76 Bn | 28.45 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.41 Bn | 10.02 Bn | 668.28 Mn |
| 8 | Insmed | 27.58 Bn | 26.42 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.24 Bn | 26.41 Bn | - |
| 10 | BioRestorative Therapies | 1.93 Mn | -1.02 Mn | 17,964.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.19 Mn |
| Sep 30, 2025 | -2.37 Mn |
| Jun 30, 2025 | 1.04 Mn |
| Mar 31, 2025 | -580,975.00 |
| Dec 31, 2024 | -469,842.00 |
| Sep 30, 2024 | 134,755.00 |
| Jun 30, 2024 | 460,566.00 |
| Mar 31, 2024 | 188,481.00 |
| Dec 31, 2023 | -470,993.00 |
| Sep 30, 2023 | -179,828.00 |
| Jun 30, 2023 | 561,334.00 |
| Mar 31, 2023 | 3.71 Mn |
| Dec 31, 2022 | -3.99 Mn |
| Sep 30, 2022 | -296,757.00 |
| Jun 30, 2022 | 869,799.00 |
| Mar 31, 2022 | 1.22 Mn |
| Dec 31, 2021 | -1.50 Mn |
| Sep 30, 2021 | -292,152.00 |
| Jun 30, 2021 | -42,497.00 |
| Mar 31, 2021 | -115,515.00 |